445 related articles for article (PubMed ID: 29190579)
1. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
Ohtsuka Y
Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
3. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
4. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
5. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
Ibrahim S; Gulab S; Ishaque S; Saleem T
BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of vigabatrin in patients with infantile spasms.
Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
[TBL] [Abstract][Full Text] [Related]
9. Steroids or vigabatrin in the treatment of infantile spasms?
Riikonen RS
Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin for infantile spasms.
Mitchell WG; Shah NS
Pediatr Neurol; 2002 Sep; 27(3):161-4. PubMed ID: 12393124
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
13. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
14. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
Shumiloff NA; Lam WM; Manasco KB
Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
Carmant L
Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
18. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
19. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
[TBL] [Abstract][Full Text] [Related]
20. Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome.
Wohlrab G; Boltshauser E; Schmitt B
Neuropediatrics; 1998 Jun; 29(3):133-6. PubMed ID: 9706623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
